Logo.png
Leigh Syndrome Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight
July 24, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 24, 2024 (GLOBE NEWSWIRE) -- Leigh Syndrome Market Anticipates Impressive Growth Trajectory Across 7MM During the Study Period (2020–2034) | DelveInsight  DelveInsight’s...
Logo.png
GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight
July 23, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 23, 2024 (GLOBE NEWSWIRE) -- GLP Agonist Clinical Trial Pipeline Appears Robust With 20+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight The...
Logo.png
Cell and Gene Therapy in Parkinson's Disease Market to Register Stunning Growth During the Study Period (2020–2034) | DelveInsight
July 22, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 22, 2024 (GLOBE NEWSWIRE) -- Cell and Gene Therapy in Parkinson's Disease Market to Register Stunning Growth During the Study Period (2020–2034) | DelveInsight  The cell and...
Logo.png
Global Peptide Therapeutics Market to Grow Significantly at a CAGR of ~10% by 2030| DelveInsight
July 17, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 17, 2024 (GLOBE NEWSWIRE) -- Global Peptide Therapeutics Market to Grow Significantly at a CAGR of ~10% by 2030| DelveInsight  The increasing prevalence of conditions like...
Logo.png
Friedreich's Ataxia Market to Grow at a Substantial Growth Rate by 2034, Examines DelveInsight | Key Companies - Retrotope, PTC Therapeutics, Minoryx Therapeutics, Biogen, Lexeo Therapeutics, Larimar Therapeutics
July 16, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 16, 2024 (GLOBE NEWSWIRE) -- Friedreich's Ataxia Market to Grow at a Substantial Growth Rate by 2034, Examines DelveInsight | Key Companies - Retrotope, PTC Therapeutics, Minoryx...
Logo.png
Bacterial Vaginosis Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight
July 15, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 15, 2024 (GLOBE NEWSWIRE) -- Bacterial Vaginosis Market to Register Incremental Growth During the Study Period (2020–2034) | DelveInsight  The current therapeutic landscape of...
Logo.png
Cystic Fibrosis Market is Projected to Boost by 2034, Predicts DelveInsight | Key Companies - Verona Pharmaceuticals, Vertex Pharmaceuticals, Krystal Biotech, Aridis Pharmaceuticals, BiomX, Inc., Boehringer Ingelheim
July 11, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 11, 2024 (GLOBE NEWSWIRE) -- Cystic Fibrosis Market is Projected to Boost by 2034, Predicts DelveInsight | Key Companies - Verona Pharmaceuticals, Vertex Pharmaceuticals, Krystal...
Logo.png
Metastatic Prostate Cancer Clinical Trial Pipeline Insights Featuring 75+ Companies | DelveInsight
July 10, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 10, 2024 (GLOBE NEWSWIRE) -- Metastatic Prostate Cancer Clinical Trial Pipeline Insights Featuring 75+ Companies | DelveInsight The metastatic prostate cancer market is driven...
Logo.png
Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - FibroGen, OSE Immunotherapeutics, Panbela Therapeutics, Lokon Pharma, Helix Biopharma, Tvardi Therapeutics, BioNTech, XBiotech, Lumicell, CARsgen Ther
July 09, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 09, 2024 (GLOBE NEWSWIRE) -- Pancreatic Cancer Market to Grow Rapidly by 2034, Predicts DelveInsight | Key Companies - FibroGen, OSE Immunotherapeutics, Panbela Therapeutics,...
Logo.png
Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
July 08, 2024 13:00 ET | DelveInsight Business Research LLP
New York, USA, July 08, 2024 (GLOBE NEWSWIRE) -- Advanced Melanoma Clinical Trial Pipeline Analysis Demonstrates 55+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm,...